e-learning
resources
Virtual 2020
Pre-Congress Content
New insight into the pathogenesis of chronic lung diseases: asthma, COPD and others
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Development and characterisation of a multi-species COPD biofilm
B. Short (Paisley, United Kingdom), C. Williams (Paisley, United Kingdom), G. Litherland (Paisley, United Kingdom), F. Lundy (Belfast, United Kingdom), W. Mackay (Paisley, United Kingdom), G. Ramage (Glasgow, United Kingdom)
Source:
Virtual Congress 2020 – New insight into the pathogenesis of chronic lung diseases: asthma, COPD and others
Session:
New insight into the pathogenesis of chronic lung diseases: asthma, COPD and others
Session type:
E-poster session
Number:
2053
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
B. Short (Paisley, United Kingdom), C. Williams (Paisley, United Kingdom), G. Litherland (Paisley, United Kingdom), F. Lundy (Belfast, United Kingdom), W. Mackay (Paisley, United Kingdom), G. Ramage (Glasgow, United Kingdom). Development and characterisation of a multi-species COPD biofilm. 2053
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Sputum biospecimen quality and suitability for microbiome characterisation in COPD
Source: International Congress 2018 – The airway microbiome across the spectrum of airway disease
Year: 2018
Variation of microbiota in COPD patients during exacerbation and posterior stabilization: molecular characterization by metagenomic.
Source: International Congress 2017 – COPD: microbiome composition and the role of antibiotics
Year: 2017
Comparison of quantitative PCR and quantitative culture for the detection of airway pathogenic bacteria in COPD
Source: International Congress 2014 – Markers
Year: 2014
High-throughput analysis of induced sputum from the U-BIOPRED study using novel proteomic and data mining approaches
Source: Annual Congress 2013 –Origins and diagnosis of asthma
Year: 2013
Applying clinical metagenomics for the detection and characterisation of respiratory infections
Source: Eur Respir Monogr 2019; 83: 35-49
Year: 2019
Influence of biofim on the bronchial microbiome in COPD patients colonized or infected by pseudomonas aeruginosa
Source: International Congress 2015 – Advances from translational research in respiratory infections
Year: 2015
LSC Abstract – Functional metagenomics of respiratoy microbiome in exacerbated COPD
Source: International Congress 2015 – Respiratory infections: from basic science to clinical issues
Year: 2015
What is bacterial colonisation in COPD?
Source: Eur Respir Monogr 2015; 69: 161-171
Year: 2015
Identification of causative bacteria in the airways of COPD by a novel semi-quantitative PCR method
Source: Annual Congress 2013 –COPD and infections
Year: 2013
Causative bacteria in protracted bacterial bronchitis are biofilm forming species
Source: International Congress 2018 – Orphan diseases in children
Year: 2018
Profiling the COPD airway microbiome using quantitative culture and 16S rRNA gene sequencing
Source: International Congress 2016 – Clinical and microbiological aspects of infections in COPD patients
Year: 2016
Lung microbiome dynamics in COPD exacerbations
Source: Eur Respir J 2016; 47: 1082-1092
Year: 2016
Distribution of a COPD population based on the GOLD assessment framework
Source: Annual Congress 2012 - Prevalences and characterstics of obstructive airway disease
Year: 2012
Analysis of microbiological colonization in COPD patients with or without bronchiectasis
Source: Virtual Congress 2020 – News on clinical evaluation of bronchiectasis, cough and inflammatory disease
Year: 2020
Functional lower airways genomic profiling of the microbiome to capture active microbial metabolism
Source: Eur Respir J, 58 (1) 2003434; 10.1183/13993003.03434-2020
Year: 2021
Identification of pleural infection microbiological patterns by applying next generation sequencing and bioinformatics analysis
Source: Virtual Congress 2020 – Antibiotic therapy for pneumonia and pleural infections
Year: 2020
COPD phenotypes revealed by the integrated sputum microbiome and proteome analysis in COPDMAP cohort
Source: International Congress 2019 – Host-microbe interactions in lung disease and exacerbations
Year: 2019
The species-specific inflammatory response of colonising bacteria in stable COPD
Source: Annual Congress 2013 –COPD: markers and inflammation
Year: 2013
Microbial colonization pattern in COPD patients with invasive and noninvasive ventilation
Source: Eur Respir J 2001; 18: Suppl. 33, 184s
Year: 2001
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept